End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37,700 KRW | -1.44% | -0.79% | -15.19% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm trades with high earnings multiples: 25.39 times its 2022 earnings per share.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.19% | 783M | - | ||
+15.09% | 74.45B | A | ||
+11.35% | 9.18B | A- | ||
+54.35% | 5.03B | - | ||
-12.85% | 5.02B | A- | ||
+1.60% | 3.82B | B- | ||
-20.85% | 2.41B | C- | ||
+16.88% | 2.39B | B | ||
-29.25% | 2.27B | - | ||
+24.62% | 2.26B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A195940 Stock
- Ratings HK inno.N Corporation